NF1 loss in estrogen receptor-positive breast cancer induces osteoclast formation and immunosuppression to promote bone metastasis
Zifan Zhao(Baylor College of Medicine), Eric C. Chang(Baylor College of Medicine), Zbigniew Gugala(University of Mary Hardin–Baylor), Meenakshi Anurag(Baylor College of Medicine), Valentina Hoyos(Baylor College of Medicine), Xiang H.-F. Zhang(Baylor College of Medicine), Fengshuo Liu(Baylor College of Medicine), Matthew V. Holt(Baylor College of Medicine), Jonathan T. Lei(Baylor College of Medicine), Owen A. Chang(Michael E. DeBakey VA Medical Center), Andres F. Mosquera Paternina(Baylor College of Medicine), Lauren K. Somes(Baylor College of Medicine), Hai Wang(Roswell Park Comprehensive Cancer Center), George Miles(Baylor College of Medicine), Omar A. Harb(Baylor College of Medicine), Igor Bado(Icahn School of Medicine at Mount Sinai), Ahmed Elkhanany(Baylor College of Medicine), Yi Li(Baylor College of Medicine), Junkai Wang(Baylor College of Medicine), Ze-Yi Zheng(Baylor College of Medicine), Yi-Hsuan Wu(Baylor College of Medicine), Matthew Baik(Baylor College of Medicine)
Cited by 1
Related Papers
Mutual regulation of tumour vessel normalization and immunostimulatory reprogramming
|Nature|2017|853
Proteogenomic insights into the biology and treatment of HPV-negative head and neck squamous cell carcinoma
|Cancer Cell|2021|382
Metastasis Dormancy in Estrogen Receptor–Positive Breast Cancer
|Clinical Cancer Research|2013|273